OR WAIT 15 SECS
© 2020 MJH Life Sciences and Pharmaceutical Executive. All rights reserved.
July 09, 2020
Gilead's pricing of COVID drug remdesivir is a reminder of pharma's tenuous path forward as it seeks a more holistic image makeover.
June 01, 2020
While scientists are striving to discover and produce safe and effective vaccines to halt the coronovirus outbreak, anti-vacciners are revving up misinformation campaigns.
May 01, 2020
Welcome to the new look and branding of Pharmaceutical Executive-reimagined to better reflect you, our audience, and expand on the content you've long trusted us to deliver.
August 13, 2019
The US could theoretically treat every single American living with HIV without spending an extra dollar on drugs. And President Trump can broker a deal to do it, write Anil Soni and Ya’ir Aizenman.
April 01, 2019
Outside of raising prices, pharma can generate new revenue from just three other sources, write Tom Kottler.
September 01, 2011
Richard Barker, former Director General of ABPI, proposes a new agenda on how to restore public confidence in the value behind science.
Despite the gloom, most forecasts show the US will stay atop the industry in profits for at least the next generation of products.
August 01, 2011
Social media now gives companies a plethora of creative ways to digitally spread recent company news and keep customers informed
HTAs are gridlocked by diverse national requirements, a lack of alignment on processes, and even on the value of their outcomes.
May 01, 2011
The UK coalition government's consultation on the intro of value-based pricing has invited caution and resistance